We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Redhill Biopharma Ltd | NASDAQ:RDHL | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0065 | -1.42% | 0.4523 | 0.4172 | 0.4625 | 0.468999 | 0.45 | 0.4625 | 257,879 | 01:00:00 |
|
REDHILL BIOPHARMA LTD.
|
|
|
|
(the "Registrant")
|
|
|
|
|
|
|
Date: February 20, 2024
|
By:
|
/s/ Dror Ben-Asher
|
|
|
Name:
|
Dror Ben-Asher
|
|
|
Title:
|
Chief Executive Officer
|
1. |
To approve an increase of the Company’s authorized share capital.
|
By Order of the Board of Directors,
|
|
Dror Ben-Asher
|
|
Chairman of the Board of Directors
|
1. |
To approve an increase of the Company’s authorized share capital.
|
We request you to carefully read this entire Proxy Statement, including the documents we refer to in this Proxy Statement. If
you have any questions, need assistance in voting, or need additional material, please contact our Strategic Shareholder Advisor and Proxy Solicitation Agent, Kingsdale Advisors:
North American Toll-Free Phone: +1-866-229-8166
Text or Call Collect Outside North America: +1-646-386-1025
Email: contactus@kingsdaleadvisors.com
|
|
|
|
|
Extraordinary General Meeting of
|
|
Extraordinary
General Meeting of RedHill Biopharma Ltd.
|
RedHill Biopharma Ltd.
|
|
to be held on March 20, 2024
|
Date: March 20, 2024
|
|
For Holders as of February 19, 2024
|
See Voting Instruction On Reverse Side.
|
|
|
Please make your marks like this: ☒ Use pen only
|
|
|
|
|
For
|
Against
|
Abstain
|
● Mark, sign and date your Voting Instruction Form.
● Detach your Voting Instruction Form.
● Return your Voting Instruction Form in the
postage-paid envelope provided.
All votes must be received by 12:00 p.m. EST, on March 15, 2024.
PROXY TABULATOR FOR
REDHILL BIOPHARMA LTD.
P.O. BOX 8016
CARY, NC 27512-9903
|
|
1.
|
To approve an increase of the Company’s authorized share capital.
|
☐
|
☐
|
☐
|
||
|
|
|
|
EVENT #
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CLIENT #
|
|
|
|
|
|
Authorized Signatures - This section must be
|
|
|
|
|
|
|
|
|
completed for your instructions to be executed.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please Sign Here
|
|
Please Date Above
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please Sign Here
|
|
Please Date Above
|
|
|
REDHILL BIOPHARMA LTD.
Instructions to The Bank of New York Mellon, as Depositary
(Must be received prior to 12:00 p.m. EST on March 15, 2024)
|
|
|
|
|
|
|
|
|
|
The undersigned registered owner of American Depositary Shares hereby requests and instructs The Bank of New York Mellon, as Depositary, to endeavor, in so far as
practicable, to vote or cause to be voted the amount of Shares or other Deposited Securities represented by such Shares of RedHill Biopharma Ltd. registered in the name of the
undersigned on the books of the Depositary as of the close of business on February 19, 2024 at the Extraordinary General Meeting of the
Shareholders of RedHill Biopharma Ltd. to be held on March 20, 2024 or any postponement or adjournment thereof in respect of the
resolutions specified on the reverse.
This Notice and the documents mentioned therein, including the Proxy Statement, as well as the proposed resolutions on the agenda, will be made available to the public on
the Company’s website http://www.redhillbio.com
NOTES:
1. Please direct the Depositary how it is to vote by placing an “X” in the appropriate
box opposite each agenda item.
2. If you do not vote or if your voting instructions are not received before the
deadline, you will be deemed to have given a discretionary proxy to the Company to vote the shares represented by your ADRs pursuant to the terms and conditions of the ADRs and the Deposit Agreement under which they
are issued.
|
|
|
1 Year Redhill Biopharma Chart |
1 Month Redhill Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions